EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.
Issue link: https://digital.eyeworld.org/i/407647
EW NEWS & OPINION 12 generosity of industry in helping the poor all over the globe, as well as the educational support in fostering these efforts." In July 2014, Operation Sight launched with 17 charitable surger- ies in South Carolina and North Carolina. In Fall 2014, Operation Sight expects to handle approxi- mately 70 more cases in Utah and California. However, additional ASCRS-member volunteer surgeons are needed to expand the network across the U.S. To become a member of the Operation Sight network or make a contribution, call the ASCRS Foundation at 703-591-2220, email info@ascrsfoundation.org, or go to ASCRSFoundation.org/ operation-sight. "I am hopeful that my colleagues will not only contribute their time and talents to the Operation Sight initiative and this very worthy cause, but also their dollars," Dr. Lane said. EW Contact information Elliot: aelliott@ascrs.org Lane: sslane@AssociatedEyeCare.com ASCRS-member surgeons and their staffs in providing care," Dr. Lane said. "Through the ASCRS Founda- tion's involvement, we've stream- lined access for patients and at the same time, minimized the admin- istrative hassles that sometimes discourage physician involvement." Industry participation will also be a big part of the ASCRS Foundation's efforts to fund charitable cataract surgeries across the country. James V. Mazzo, an ASCRS Foundation Governing Board member, will act as the lead for in- volving industry in Operation Sight. Mr. Mazzo is chairman and CEO of AcuFocus (Irvine, Calif.) as well as a Newport Beach-based operating partner of Versant Ventures. "I believe Jim [Mazzo] will be incredibly effective in this role," Dr. Lane said. "It's curious that while there is occasional criticism of the relationships between MDs and industry, you seldom hear about the Reference: 1. Data on file. LENSAR, Inc. The LENSAR Laser System – fs 3D (LLS-fs 3D) is intended for use in patients undergoing cataract surgery for removal of the crystalline lens. Intended uses in cataract surgery include anterior capsulotomy, laser phacofragmentation, and the creation of full and partial thickness single-plane and multi-plane arc cuts/incisions in the cornea, each of which may be performed either individually or consecutively during the same procedure. Laser Capsulotomy, laser phacofragmentation and/or corneal incisions surgery is contraindicated in patients: who are of pediatric age, whose pupils will not dilate or remain dilated to a diameter greater than that of the intended treatment and for capsulotomies and/or laser phacofragmentation with intended diameters of less than 4 mm or greater than 7 mm, who have existing corneal implants, who have previous corneal incisions that might provide a potential space into which the gas produced by the procedure can escape, who have conditions that would cause inadequate clearance between the intended capsulotomy cut and the corneal endothelium, such as: hypotony, uncontrolled glaucoma, who have corneal disease or pathology that precludes transmission of light at the laser wavelength or causes distortion of laser light, such as: corneal opacities, residual, recurrent, active ocular or uncontrolled eyelid disease or any corneal abnormalities (including endothelial dystrophy, guttata, recurrent corneal erosion, etc.) in the eye to be treated, ophthalmoscopic signs of keratoconus (or keratoconus suspect) in the eye to be treated, a history of severe dry eye that has not responded to therapy, a history of herpes zoster or herpes simplex keratitis. Potential contraindications are not limited to those included in the list. WARNING: The safety and effectiveness of this laser have NOT been established in patients with diabetic retinopathy, a history of treated glaucoma, or prior intraocular surgery. © 2014 LENSAR, Inc. All rights reserved. LENSAR and the LENSAR logo are registered trademarks and Augmented Reality is a trademark of LENSAR, Inc. 50-00078-000 Rev. B 09/14 The LENSAR ® Laser System can help you make all the right moves in femtosecond laser cataract surgery. That's because LENSAR was thoughtfully designed from the ground up to meet the needs of cataract surgeons, with unique features that increase workflow and procedural efficiencies, reduce CDE up to 100%, 1 and create a safe patient experience. And now with pending capabilities to connect with pre- and post-op diagnostics, LENSAR can help you further refine outcomes for increased accuracy and greater patient satisfaction. Learn more about LENSAR's winning combination of features at www.LENSAR.com. THINK STRATEGIC Ending treatable cataract blindness continued from page 11 November 2014 Send us your favorite app! Have a favorite app that helps you with business or personal activities? Email stacy@eyeworld.org with the app name and how it helped you. Apps selected will be published in Ophthalmology Business.